Showing results (1051-1060 of 3,507) with videos related to

Sort By:
Pageof 351
Eclinicalmedicine|October 16, 2023
Anogenital injury following sexual assault and consensual sexual intercourse: a systematic review and meta-analysisDavid N Naumann, Louise Morris, Douglas M Bowley, et al.
Eclinicalmedicine|October 16, 2023
The burden of non-communicable diseases among people living with HIV in Sub-Saharan Africa: a systematic review and meta-analysisMaureen Moyo-Chilufya, Kuhlula Maluleke, Kabelo Kgarosi, et al.
Eclinicalmedicine|October 19, 2023
Safety and efficacy of multimatrix mesalamine in paediatric patients with mild-to-moderate ulcerative colitis: a phase 3, randomised, double-blind studyNicholas Michael Croft, Bartosz Korczowski, Jarosław Kierkuś, et al.
Eclinicalmedicine|October 25, 2023
A framework for the definition and interpretation of the use of surrogate endpoints in interventional trialsOriana Ciani, Anthony M Manyara, Philippa Davies, et al.
Eclinicalmedicine|October 25, 2023
Ultra-low-dose CT vs. chest X-ray in non-traumatic emergency department patients - a prospective randomised crossover cohort trialChristian Wassipaul, Karin Janata-Schwatczek, Hans Domanovits, et al.
Eclinicalmedicine|October 9, 2023
Sex-related differences in functional capacity and its implications in risk stratification before major non-cardiac surgery: a post hoc analysis of the international METS studyJonas Alfitian, Bernhard Riedel, Hilmy Ismail, et al.
Eclinicalmedicine|October 6, 2023
Efficacy of intravenous immunoglobulins (IVIg) in improving skin symptoms in patients with dermatomyositis: a post-hoc analysis of the ProDERM studyVictoria P Werth, Rohit Aggarwal, Christina Charles-Schoeman, et al.
Eclinicalmedicine|September 28, 2023
Treat-to-target versus high-intensity statin treatment in patients with or without diabetes mellitus: a pre-specified analysis from the LODESTAR trialSeung-Jun Lee, Woong Chol Kang, Jong-Young Lee, et al.
Eclinicalmedicine|October 2, 2023
Combined therapy with ibrutinib and bortezomib followed by ibrutinib maintenance in relapsed or refractory mantle cell lymphoma and high-risk features: a phase 1/2 trial of the European MCL network (SAKK 36/13)Urban Novak, Martin Fehr, Sämi Schär, et al.
Eclinicalmedicine|October 3, 2023
Tocilizumab in combination with a standard induction chemotherapy in acute myeloid leukaemia patients (TOCILAM study): a single-centre, single-arm, phase 1 trialPierre Peterlin, Alice Garnier, Amandine Le Bourgeois, et al.
Pageof 351